E2 ModerateModerate confidencePEM not requiredCross-SectionalPeer-reviewedReviewed
Standard · 3 min
Diminished central activation during maximal voluntary contraction in chronic fatigue syndrome.
Schillings, M L, Kalkman, J S, van der Werf, S P et al. · Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology · 2004 · DOI
Quick Summary
This study compared how the brains and muscles of ME/CFS patients and healthy people control muscle strength during a sustained squeeze test. Researchers found that ME/CFS patients had weaker voluntary control from their brain to their muscles at the start of the task, even though their muscles themselves were less fatigued afterward. This suggests that in ME/CFS, the problem may originate from reduced brain-to-muscle signaling rather than muscle weakness itself.
Why It Matters
This study provides objective neurophysiological evidence that reduced brain-to-muscle signaling contributes to exercise limitation in ME/CFS, moving beyond subjective symptom reporting. Understanding this central mechanism could help validate ME/CFS as a physiological condition and guide development of targeted interventions based on the underlying cause rather than symptoms alone.
Observed Findings
ME/CFS patients showed significantly lower maximal voluntary contraction force compared to controls.
Central activation failure was significantly higher in patients at the beginning of sustained contraction (36.5±17.0% vs 12.9±13.3%).
All 14 ME/CFS patients maintained central activation failure above 30% for the first 45 seconds, while all 14 controls remained below 30%.
Patients demonstrated less change in muscle fiber conduction velocity and force recovery, indicating reduced peripheral muscle fatigue.
Force responses to electrical stimulation at rest were not significantly different between groups.
Inferred Conclusions
Central activation is diminished in ME/CFS patients during maximal voluntary contraction.
Reduced central drive results in lower demands on muscles, protecting them from peripheral fatigue.
Possible causes of impaired central activation include altered perception, reduced concentration, reduced effort, or physiological changes in corticospinal excitability or neurotransmitter function.
The underlying pathophysiological mechanisms driving central activation failure in ME/CFS remain undetermined.
Remaining Questions
What specific neurobiological mechanisms cause the impaired central activation (e.g., corticospinal excitability, neurotransmitter dysfunction, or perception-based factors)?
What This Study Does Not Prove
This study does not prove that central activation failure is the only cause of exercise intolerance in ME/CFS, nor does it establish the specific neurological or biochemical mechanisms responsible for the impaired signaling. The cross-sectional design cannot determine whether reduced central activation is a primary disease feature or a secondary adaptation, and results are limited to a single muscle group in female participants only.
Tags
Symptom:Fatigue
Biomarker:Neuroimaging
Method Flag:Small SampleStrong PhenotypingSex-StratifiedWeak Case Definition
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.